Telehealth Certificate

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This continuing pharmacy education activity is intended for pharmacists and pharmacy technicians seeking to expand their knowledge and skills in telehealth management.

Exploring the Telehealth Evolution
0204-0000-22-784-H04-P&T

• Explain how the history of telehealth has contributed to the current application of today’s technology in healthcare.pharmacogenomics to optimize medication use.
• Use the accepted definitions and terminology for telehealth practice.
• Define the current types of telehealth methods and potential clinical applications.
• Compare telehealth technologies to differentiate their use.
• Summarize the evidence in literature of research for telehealth clinical practice.Define basic genomic terminology.
• Assess telehealth service platforms and networks.
• Describe the state and federal policies that guide telehealth practice.
• Identify barriers to implementing and sustaining a telehealth program.

Defining the Telehealth Phamacy Practice Environment
0204-0000-22-785-H04-P&T

• Analyze practice environment factors for designing a successful telehealth practice.
• Construct a plan that strengthens interdisciplinary team relationships in a telehealth care model to maximize the benefits and value for patients and patient care team.
• Identify key workflow elements to consider prior to, during, and after a telehealth pharmacy practice visit.
• Construct a workflow for telehealth pharmacy practice visits.
• Recommend methods of patient selection, recruitment, and retention for telehealth visits.
• Differentiate types of wearable technology.
• Given a case, recommend adjustments to improve patient management in a telehealth visit.
• Identify key metrics used for patient assessment during annual wellness visits (AWVs) in telehealth appointments.
• Summarize the core components of a comprehensive medication management program, including the benefits realized by both patients and health systems.
• Given a telehealth patient case, apply the pharmacist Patient Care Process.

Managing Telehealth Pharmacy Billing
0204-0000-22-786-H04-P&T

• Assess the differences between payers for an ambulatory patient practice.
• Identify the conditions and basic elements that are required for a healthcare practitioner to bill for services.
• Describe the rules and challenges for pharmacists to bill for services based on current regulations and location of service. pharmacogenomics resources.
• Compare types of billing models used in telehealth pharmacy care.
• Differentiate the code sets for telehealth pharmacy care billing.
• Identify billing opportunities available for telehealth pharmacy care delivered in a federally qualified health center (FQHC).
• Develop a workflow for delivering billable diabetes care via telehealth in a FQHC.
• Differentiate between types of value-based care models.
• Create a scorecard to highlight outcomes of telehealth in a value-based payment model.

Telehealth Patient Care Models
0204-0000-22-787-H04-P&T

• Identify the criteria required to use Principal Care Management (PCM) and Chronic Care Management (CCM) codes.
• Design a clinic model using PCM and CMM codes.
• Identify requirements of Transitional Care Management (TCM) billing.
• Apply TCM billing to a telehealth model, including appropriate outcome tracking.
• Describe remote physiologic monitoring (RPM), including its unique requirements for billing.
• Compare different modalities of acquiring remote physiologic data for application in practice.

Continuous Quality Improvement through Telehealth Metrics Management
0204-0000-22-788-H04-P&T

• Summarize the importance of a well-defined quality assurance framework for telehealth care models.
• Prioritize quality assessment metrics for a telehealth service. Apply TCM billing to a telehealth model, including appropriate outcome tracking.
• Contrast the advantages and disadvantages of care delivery through telehealth models.
• Compare surveys used to evaluate patient experience in traditional and telehealth settings.
• Choose a telehealth satisfaction questionnaire appropriate for the metrics of interest.
• Choose a basic clinical audit appropriate for the telehealth setting.
• Recommend processes that measure and promote medication safety during telehealth pharmacy practice encounters.
• Identify metrics that reflect the utilization and effectiveness of telehealth encounters.
• Select metrics that provide information relating to access to care that may be impacted by telehealth.
• Assess metrics relating to the financial impact of telehealth services in order to predict and track sustainable telehealth pharmacy practice models.
• Apply patient satisfaction tools to track patient experience during telehealth encounters.
• Analyze methods of sharing metrics for communicating to stakeholders the quality of telehealth services.

Training Considerations for Telehealth Management
0204-0000-22-789-H04-P&T

• Assess qualities of a successful telehealth care learning experience.
• Create a telehealth care learning environment that both meets the needs of patients and students.
• Analyze the features of telehealth software needed for a successful patient and learner experience.
• Apply a tool to telehealth software for evaluating necessary components.
• Summarize the different types of consent required for creating successful telehealth learning environments.
• Develop practice methods to improve communication between learners, patients, and preceptors before, during, and after a patient encounter.
• Apply strategies to provide timely formative feedback in the telehealth practice setting.
• Design a thorough formal evaluation of telehealth practice activities that ensures accreditation and residency standards are met.

Learning Activity	ACPE Number	Contact Hours
Exploring the Telehealth Evolution	0204-0000-22-784-H04-P&T	4.0
Defining the Telehealth Pharmacy Practice Environment	0204-0000-22-785-H04-P&T	3.25
Managing Telehealth Pharmacy Billing	0204-0000-22-786-H04-P&T	3.0
Telehealth Patient Care Models	0204-0000-22-787-H04-P&T	2.25
Continuous Quality Improvement through Telehealth Metrics Management	0204-0000-22-788-H04-P&T	3.5
Training Considerations for Telehealth Management	0204-0000-22-789-H04-P&T	2.5
→  Final Assessment (80% passing score required)

Melissa E. Badowski, PharmD, MPH, FCCPD, BCIDP, BCPS, AAHIVP
Clinical Associate Professor
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois

Andrea Darr, PharmD, BCPS
Vice President & General Manager
Pharmacy Services
Avel eCare
Sioux Falls, South Dakota

Starlin Haydon-Greatting, MS-MPH, BSPHarm, CDM, FAPhA
Pharmacoepidemiologist/Health Economics
SHG Clinical Consulting
Springfield, Illinois

Mary Ann Kliethermes, BSPharm, PharmD, FAPhA, FCIOM
Director of Medication Safety and Quality
American Society of Health-System Pharmacists
Bethesda, Maryland

Brody Maack, PharmD, BCACP, CTTS
Associate Professor of Practice
North Dakota State University School of Pharmacy
Clinical Pharmacy Specialist
Family HealthCare
Fargo, North Dakota

Michelle McElhannon, PharmD
Ambulatory Specialty Pharmacist
Athens Neighborhood Health Center
Athens, Georgia

Jeffery L. Olson, PharmD, MBA, BCPS, BCACP
System Pharmacy Operations Director
Intermountain Healthcare
Salt Lake City, Utah

Jennifer Reiter, PharmD, MBA, BCACP, BCPS, BC-ADM
Pharmacy Manager – Ambulatory Care
Indiana University Health
Bloomington, Indiana

Angelina Vascimini, PharmD
Assistant Professor
University of South Florida
Taneja College of Pharmacy
Tampa, Florida

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

The following persons in control of this activity’s content have relevant financial relationships:

• Andrea Darr: Avel eCare, employee

All other persons in control of content do not have any relevant financial relationships with an ineligible company.

As required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.

This online activity consists of a combined total of 6 learning modules. Pharmacists are eligible to receive a total of 18.5 hours of continuing education credit by completing all 6 modules within this certificate.

Participants must participate in the entire activity, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center.  Follow the prompts to claim credit and view your statement of credit within 60 days of completing the activity.

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline.   After the 60 day deadline, ASHP will no longer be able to award credit for this activity.